Aytu BioPharma Inc (AYTU) reports a mixed quarter with decreased revenues but a promising start for its novel depression treatment, EXXUA.
Aytu BioPharma, Inc. ( AYTU) Q2 2026 Earnings Call February 3, 2026 4:30 PM EST Good day, everyone, and welcome to the Aytu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results